4WM
AZN icon

44 Wealth Management’s AstraZeneca AZN Stock Holding History

44 Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.29M Sell
6,536
-68
-1% -$13.1K 0.45% 81
2025
Q4 		$1.21M Sell
6,604
-1,757
-21% -$308K 0.41% 87
2025
Q3 		$1.28M Buy
8,361
+62
+0.7% +$9.38K 0.44% 84
2025
Q2 		$1.16M Buy
8,299
+1,568
+23% +$220K 0.41% 82
2025
Q1 		$989K Buy
6,731
+1,206
+22% +$174K 0.37% 92
2024
Q4 		$724K Sell
5,525
-645
-10% -$90.3K 0.28% 103
2024
Q3 		$950K Buy
+6,170
New +$996K 0.33% 94
2023
Q2 		$912K Sell
6,368
-761
-11% -$112K 0.31% 76
2023
Q1 		$990K Sell
7,129
-2,217
-24% -$298K 0.33% 72
2022
Q4 		$1.27M Buy
9,346
+114
+1% +$14.3K 0.44% 60
2022
Q3 		$1.01M Sell
9,232
-412
-4% -$52.3K 0.42% 65
2022
Q2 		$1.27M Buy
9,644
+255
+3% +$33.5K 0.49% 53
2022
Q1 		$1.25M Buy
9,389
+114
+1% +$13.7K 0.45% 60
2021
Q4 		$1.08M Sell
9,275
-146
-2% -$17.2K 0.37% 67
2021
Q3 		$1.13M Sell
9,421
-95
-1% -$11.1K 0.43% 60
2021
Q2 		$1.14M Buy
9,516
+2,226
+31% +$244K 0.44% 58
2021
Q1 		$725K Buy
7,290
+2,498
+52% +$251K 0.3% 76
2020
Q4 		$479K Buy
+4,792
New +$508K 0.22% 99

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

44 Wealth Management's AZN Position: Q1 2026 in Review

44 Wealth Management reduced its AstraZeneca (AZN) stake by 1% in Q1 2026, selling an estimated $13.1K and leaving 6,536 shares worth $1.29M. The position accounts for 0.45% of the portfolio, ranked #81.

44 Wealth Management first reported a position in AZN in Q4 2020 and has held it in 18 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • 44 Wealth Management held 6,536 shares of AstraZeneca worth $1.29M as of Q1 2026.
  • 44 Wealth Management sold 68 AstraZeneca shares in Q1 2026, an estimated $13.1K.
  • AstraZeneca made up 0.45% of 44 Wealth Management's portfolio in Q1 2026, its #81 holding.
  • 44 Wealth Management first reported a position in AstraZeneca in Q4 2020 and has held it in 18 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on 44 Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.